LGG-49. SAFETY AND EFFICACY OF TRAMETINIB (T) MONOTHERAPY AND DABRAFENIB + TRAMETINIB (D+T) COMBINATION THERAPY IN PEDIATRIC PATIENTS WITH <i>BRAF</i> V600-MUTANT LOW-GRADE GLIOMA (LGG)

Authors: Eric Bouffet, James A Whitlock, Christopher Moertel, Birgit Geoerger, Isabelle Aerts, Darren Hargrave, Kenneth J Cohen, Lindsay B Kilburn, Santhosh A Upadhyaya, Cynthia Wetmore, Karen D Wright, Jeea Choi, Eduard Gasal, Mark W Russo, Elizabeth Fox

Published: 2020-12-04

DOI: 10.1093/neuonc/noaa222.427

Source: Full article

LGG-49. SAFETY AND EFFICACY OF TRAMETINIB (T) MONOTHERAPY AND DABRAFENIB + TRAMETINIB (D+T) COMBINATION THERAPY IN PEDIATRIC PATIENTS WITH <i>BRAF</i> V600-MUTANT LOW-GRADE GLIOMA (LGG)

Abstract